Wikidata

(Q50327327)

English

21. Evaluation of the Efficacy, Safety, and Tolerability of BI 409306, a Novel Phosphodiesterase 9 Inhibitor, in Cognitive Impairment in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Phase II Study.

scientific article published on 20 March 2017

In more languages

Statements

title
21. Evaluation of the Efficacy, Safety, and Tolerability of BI 409306, a Novel Phosphodiesterase 9 Inhibitor, in Cognitive Impairment in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Phase II Study (English)
1 reference
stated in
Europe PubMed Central
PMCID
5475484
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC5475484&resulttype=core&format=json
retrieved
13 May 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q50327327&oldid=1598879200"